GARDP and Evotec announce new partnership to discover novel antibiotics

[Geneva/Hamburg – 19 March 2019]

GARDP and Evotec AG are announcing the formation of a new strategic public-private partnership to tackle the growing threat of antimicrobial resistance (AMR). By joining forces, Evotec and GARDP will leverage their capabilities and networks to address drug-resistant bacterial infections.